Patent · US Active

Minimal volume reprogramming of mononuclear cells

US10023879B2 · kind B2 · utility

11Cited by
4References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 4, 2015
Grant dateJul 17, 2018
Priority date
Expiry dateJun 4, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2840/20
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides compositions and methods for reprogramming minimal volumes of mononuclear cells. In particular aspects, the invention provides methods and compositions for reprogramming minimal volumes of umbilical cord blood obtained from cord blood segments from cryopreserved cord blood segments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.